EvidentIQ Q&A
Dacima Software’s ownership change, effective July 1, 2022, brings faster growth, an expanded global presence, and exciting new product developments—while maintaining existing studies, agreements, and service quality. Contact Dr. John Podoba for more details.
Dacima has joined the EvidentIQ Group
As of July 1, 2022, Dacima is part of the EvidentIQ Group, enhancing our global reach and innovation while maintaining our team, name, and commitment to excellence. Business continues as usual!
Happy Holidays
DACIMA team wishes you a happy holiday and healthy New Year! The past year has not been easy for everyone. We are so grateful for your continued support and partnership.
Results of COLCORONA study on ways to prevent morbidity and mortality related to COVID-19
The Montreal Heart Institute has released results from the COLCORONA study on reducing COVID-19 morbidity and mortality. Dacima is proud to have been a technology partner in this critical clinical trial.
Movember to Launch World’s First Cancer Registry ‘Super Network’
Movember is creating the world’s largest prostate cancer patient registry network, harnessing real-world data from over 130,000 men to transform treatment and care. In a landmark partnership, Dacima Software will design a cutting-edge registry database, integrating global patient data for improved outcomes, faster clinical trials, and personalized care.
Coronavirus outbreak and potential impact on clinical data
Dacima collaborates with research institutes and government agencies to enhance healthcare services during the COVID-19 pandemic. Our secure, efficient, and cost-effective EDC platform accelerates outbreak research and response with accurate data collection and analytics.
DACIMA providing randomization (IWRS), supply management and drug accountability software for the COLCORONA trial on COVID-19
Dacima Clinical Suite’s web randomization, supply management, and drug accountability modules are powering the COLCORONA trial by the Montreal Heart Institute, funded by the Quebec government. Dacima remains committed to supporting COVID-19 research with its flexible, cloud-based EDC platform designed for efficient and user-friendly study databases.
Dacima at HIMSS20
Dacima will participate in HIMSS20 in Orlando Florida from March 9-13, 2020. Visit us at booth #3829 to learn more about Dacima Clinical Suite which includes EDC, IWRS, supply management, ePRO, eDiary medical coding, eConsent, monitoring features and much more.
